Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

How to Reconstitute BPC 157: Our Team’s Step-by-Step Method

You’ve made a crucial decision for your research project and acquired high-purity, lyophilized BPC 157. That’s a fantastic start. But here’s a truth our team has seen play out time and time again: the most pristine peptide in the world is rendered completely u

You’ve made a crucial decision for your research project and acquired high-purity, lyophilized BPC 157. That’s a fantastic start. But here’s a truth our team has seen play out time and time again: the most pristine peptide in the world is rendered completely useless, or worse, misleading, if it’s prepared incorrectly. That delicate, chalky puck of powder at the bottom of the vial holds immense potential, but only if you know how to properly bring it back to life.

This process, known as reconstitution, isn't just a formality. It's a foundational scientific procedure that dictates the stability, efficacy, and ultimately, the validity of your research outcomes. At Real Peptides, we don't just see ourselves as suppliers; we're partners in discovery. Our commitment to quality extends beyond the small-batch synthesis of our products. It includes empowering researchers like you with the knowledge to handle these sensitive compounds with the precision they demand. We've seen the unfortunate aftermath of improper handling, and we’re here to make sure you get it right from the very beginning.

Why Proper Reconstitution is Non-Negotiable

Let's get straight to the point. Lyophilization, or freeze-drying, is the gold standard for preserving the intricate structure of peptides like BPC 157 Peptide. This process removes water under low pressure, transforming the peptide into a stable, powdered state that can withstand transport and storage without degrading. It’s a delicate, sophisticated process designed for maximum preservation.

The moment you introduce a liquid, you're reversing that process. And how you do it matters. Immensely. The amino acid chains that make up the peptide are formidable but also fragile. Introducing the reconstitution liquid too forcefully, using the wrong kind of liquid, or shaking the vial can physically shear these chains apart. It’s like trying to untangle a delicate necklace with a hammer. The result is a solution containing broken, ineffective fragments of the original compound. Your research from that point on? Compromised.

We can't stress this enough: the integrity of your entire project hinges on this single, critical step. It’s the bridge between a stable, pure compound and a usable, active solution. Cutting corners here isn't just sloppy science; it’s a catastrophic waste of time, resources, and the peptide itself.

Gathering Your Essential Supplies

Before you even think about touching a vial, you need to assemble your toolkit. Working with research peptides demands a laboratory mindset, even if your workspace is modest. Having everything clean, organized, and within arm's reach prevents costly mistakes. Here’s what our protocol requires:

Lyophilized BPC 157 Vial: The starting point. Ours comes sealed to ensure purity and sterility from our lab to yours.

Bacteriostatic Water: This is the industry standard for reconstitution. It's sterile water that contains 0.9% benzyl alcohol, which acts as a preservative. This tiny addition is what inhibits bacterial growth, allowing you to draw from the vial multiple times for your research without fear of contamination. We offer high-quality Bacteriostatic Water specifically for this purpose.

An Insulin or Mixing Syringe: You'll need a sterile syringe, typically 1mL (100 units), to accurately measure and transfer the bacteriostatic water. The fine needle is essential for piercing the rubber stopper without damaging it.

Alcohol Prep Pads: Sterility is paramount. You'll use these to wipe the rubber stoppers on both your BPC 157 vial and your bacteriostatic water vial before every puncture.

That’s it. It’s a short list, but every item is non-negotiable for a successful outcome.

A Note on Your Workspace: The Unsung Hero of Good Science

This is a detail so simple that it's shockingly easy to overlook. Your environment matters. You are not making a cocktail; you are preparing a sensitive biological compound for a scientific study. Any contaminants introduced at this stage—dust, microbes from your hands, residue on the countertop—can end up in your final solution.

Our team recommends a simple but strict pre-procedure checklist. First, thoroughly wash your hands with soap and water. Second, find a clean, flat, and well-lit surface, away from drafts or open windows. Third, wipe down that entire surface with a disinfectant. These simple actions take less than two minutes and can be the difference between clean data and a confounded experiment. We've seen it happen. Don't let a simple oversight invalidate your hard work.

The Step-by-Step Reconstitution Protocol: Our Method

Alright, you've got your supplies and a clean workspace. Now for the main event. Follow these steps precisely. Do not rush. Precision and patience are your best friends here.

Step 1: Prepare the Vials

If your BPC 157 and bacteriostatic water vials have plastic caps, pop them off to expose the rubber stoppers underneath. Take an alcohol prep pad and vigorously wipe the top of each rubber stopper. Let them air dry for a moment. This sterilizes the surface you're about to puncture with the needle.

Step 2: The All-Important Calculation

This is where you need to be meticulous. Your calculation determines the final concentration of your peptide solution. A common scenario is reconstituting a 5mg vial of BPC 157. The amount of bacteriostatic water you add is up to you, but it dictates how potent each unit or mL of the solution will be.

Let’s use a simple example for clarity:

Vial Size: 5mg of BPC 157

1mg = 1000mcg, so you have 5000mcg of BPC 157.

Amount of Water: Let's say you decide to add 2mL of bacteriostatic water.

Now, you calculate the concentration:

Concentration = Total Peptide Amount / Total Liquid Volume

5000mcg / 2mL = 2500mcg per mL

Since a standard 1mL insulin syringe has 100 units, you can break it down further:

2500mcg per 100 units

250mcg per 10 units

25mcg per 1 unit

Knowing this exact concentration is absolutely essential for accurate dosing in your research protocol. Double-check your math. Then check it again.

Step 3: Draw the Bacteriostatic Water

Uncap your sterile syringe. Pull the plunger back to the mark of the volume you calculated (in our example, 2mL or two full 1mL syringes). This fills the syringe with air. Insert the needle through the sterilized rubber stopper of the bacteriostatic water vial. Inject the air into the vial. This equalizes the pressure and makes it much easier to draw the liquid out. Now, invert the vial and slowly pull the plunger back, drawing exactly 2mL of water into the syringe. Remove the needle from the vial.

Step 4: Introduce the Water to the Peptide (The Delicate Part)

This is the most critical physical step in the entire process. Take the syringe filled with bacteriostatic water and insert the needle through the sterilized rubber stopper of the BPC 157 vial. Here's the key: DO NOT inject the water directly onto the lyophilized powder. This forceful stream can damage the peptide.

Instead, angle the needle so that the tip is touching the inside glass wall of the vial. Slowly and gently push the plunger, allowing the water to trickle down the side of the glass and pool at the bottom. The powder will begin to dissolve as the water is introduced. It’s a much gentler method that protects the integrity of the compound.

Step 5: Gentle Mixing (No Shaking!)

Once all the water has been added, remove the syringe. You'll notice the powder is mostly dissolved, but not completely. To finish the process, you must mix it gently. Do not shake the vial. We repeat: NEVER SHAKE THE VIAL. Shaking creates shearing forces that will destroy the peptide chains.

Instead, gently roll the vial between your palms. You can also swirl it lightly with your fingertips. Continue this gentle motion until the powder is completely dissolved and the solution is perfectly clear. This should only take a minute or two.

Step 6: Inspect for Clarity

The final, properly reconstituted solution should be crystal clear. Hold it up to a light source. If you see any cloudiness, discoloration, or floating particles, something has gone wrong. It could be a sign of contamination or that the peptide has been damaged. Our professional guidance is unequivocal: do not use a cloudy solution in your research. It's not worth the risk of invalid data.

Choosing Your Reconstitution Liquid: A Critical Decision

While bacteriostatic water is our team's go-to recommendation for most applications, it's helpful to understand the other options and why they might be used in specific research contexts. The choice of liquid is a critical variable.

Bacteriostatic Water

Multi-use vials for ongoing research

Contains 0.9% benzyl alcohol to prevent bacterial growth

The overwhelming standard. Ideal for nearly all peptide research due to its stability and sterile properties.

Sterile Water

Single-use applications only

Pure H2O with no preservatives

Use only if the entire vial will be used in one session. Without a preservative, it's prone to contamination after the first use.

Acetic Acid 0.6%

Specific peptides that require an acidic pH for stability

Low pH solution

Only use if explicitly required by the peptide's data sheet. Unnecessary for BPC 157 and can damage other peptides.

Sterile Saline (0.9% NaCl)

Some specific in-vivo applications

Isotonic solution

Generally not recommended for initial reconstitution as it can affect peptide stability and solubility compared to sterile or BAC water.

For BPC 157 and the vast majority of peptides used in research, including compounds like TB 500 Thymosin Beta 4 or Ipamorelin, bacteriostatic water is the superior choice for its safety, stability, and ease of use.

Storage: Protecting Your Research Investment

Reconstitution is only half the battle; proper storage ensures the solution remains stable and potent for the duration of your study.

Before Reconstitution: The lyophilized powder is quite stable. For long-term storage (months to years), keep it in the freezer. For short-term storage (a few weeks), a cool, dark place like a cupboard is sufficient. Always protect it from light.

After Reconstitution: This is where the rules change dramatically. Once in liquid form, the BPC 157 solution must be stored in the refrigerator (around 2-8°C or 36-46°F). Do not freeze the reconstituted liquid, as the freeze-thaw cycle can damage the peptide structure.

The benzyl alcohol in bacteriostatic water helps preserve the solution, typically giving it a shelf life of around 4-5 weeks when refrigerated. If you used sterile water, the shelf life plummets to just a few days due to the risk of bacterial growth.

Common Mistakes We See (And How to Avoid Them)

Our team consults with researchers regularly, and we've identified a few recurring errors that can derail a project before it even begins. Here’s what to watch out for:

The Dreaded Shake: We've said it multiple times, but it bears repeating. Shaking is the number one peptide killer. Always swirl or roll gently.

Using the Wrong Water: Using tap water, distilled water, or any other non-sterile liquid is an absolute no-go. These contain impurities and microbes that will contaminate your peptide and invalidate your results.

Botching the Math: An incorrect calculation throws off every single data point that follows. Measure twice, calculate three times. Write it down and have a colleague check it if possible. Precision here is not optional.

Skipping Sterile Procedure: Forgetting to wipe the stoppers or using a non-sterile syringe is an open invitation for bacteria. Treat every step as if you were in a cleanroom environment. It's that important.

Improper Storage: Leaving your reconstituted vial on the lab bench at room temperature for a day can significantly degrade its potency. Once it's liquid, the refrigerator is its only safe home.

Avoiding these pitfalls isn't complicated. It just requires diligence and a respect for the scientific process. It's about building good habits that ensure your results are reliable and repeatable.

The Real Peptides Difference: Why Purity Matters from the Start

We've focused heavily on the process because it's that important. But the process can only be as good as the product you start with. At Real Peptides, our entire philosophy is built on providing an impeccably pure foundation for your work. Our small-batch synthesis and rigorous quality control mean you're not just getting BPC 157; you're getting a compound with the exact amino-acid sequencing, free from the contaminants and fillers that plague lower-quality sources.

When you start with a peptide that has a verified purity of over 99%, you eliminate a massive variable from your research. You can be confident that the effects you observe are from the compound itself, not from some unknown impurity. This commitment to quality is the thread that runs through our entire catalog, from foundational peptides to more complex molecules like Tirzepatide or our innovative stacks. When you're ready to ensure your research is built on a foundation of absolute quality, we invite you to explore our full collection of research peptides. Get Started Today.

Ultimately, mastering the art of reconstitution is about more than just following steps. It’s about adopting a mindset of precision. It’s an acknowledgment that in the world of advanced biological research, the small details are everything. They separate ambiguous outcomes from breakthrough discoveries. By handling your materials with care and respect, you honor the investment you've made and set your project on the path to success.

Frequently Asked Questions

The amount is flexible and determines the final concentration. Using 1mL makes calculations simple (500mcg per 10 units), while using 2mL creates a more dilute solution (250mcg per 10 units). Choose the volume that best suits your research protocol’s dosing requirements.

Absolutely not. You must use a sterile liquid, preferably bacteriostatic water. Tap water and other non-sterile liquids contain bacteria and impurities that will contaminate and ruin the peptide, rendering your research invalid.

Shaking introduces strong shearing forces that can physically break the fragile peptide bonds. This permanently damages the compound’s structure, destroying its biological activity. Always mix by gently swirling or rolling the vial.

A properly reconstituted peptide solution should be perfectly clear. If it’s cloudy, it could be a sign of contamination or peptide degradation. Our team strongly advises against using any cloudy solution in your research.

When reconstituted with bacteriostatic water and stored correctly in the refrigerator (2-8°C), BPC 157 is generally stable for about 4 to 5 weeks. If you use sterile water, its stability drops to only a few days.

For long-term storage lasting several months or more, the freezer is the ideal place for lyophilized powder. For short-term storage of a few weeks before use, a cool, dark place away from light is sufficient.

Yes, it is perfectly normal. Many manufacturers, including us, seal vials under a slight vacuum to ensure sterility and stability during transport. You may hear a faint hiss as you puncture the stopper for the first time.

We generally do not recommend this. While some plastics used in syringes are inert, there is a risk of the peptide binding to the plastic over time, which could alter the effective dose. It’s best practice to draw each dose fresh from the vial.

Peptides are far more stable in a lyophilized (freeze-dried) powder state. Selling them as a pre-mixed liquid would dramatically shorten their shelf life and make them susceptible to degradation during shipping and storage.

It’s best to allow the bacteriostatic water to come to room temperature before mixing. While not strictly necessary, using extremely cold water can sometimes slow the dissolution process slightly. Room temperature water works perfectly.

It’s crucial to source your bacteriostatic water from a reputable supplier to ensure its sterility. We offer lab-grade [Bacteriostatic Water](https://www.realpeptides.co/products/bacteriostatic-water/) on our site, designed specifically for reconstituting research peptides.

Both are remarkable research peptides, but they have different structures and areas of focus. BPC 157 is a pentadecapeptide known for its systemic effects, while [TB 500 Thymosin Beta 4](https://www.realpeptides.co/products/tb-500-thymosin-beta-4/) is a different peptide studied for its role in cellular migration and regeneration. They are often researched together.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

PROCEDURE

How to Reconstitute BPC-157: Step-by-Step Guide (2026)

How to Reconstitute BPC-157: Step-by-Step Guide (2026) Learn how to reconstitute BPC-157 with bacteriostatic water. Covers supplies, concentration math, step-by-step mixing, storage, and common mistakes. How to reconstitute BPC-157 means dissolving lyophilized (freeze-dried) BPC-157 powder into bacteriostatic water to create a solution with a known concentration. The process takes under five minutes, requires basic sterile technique, and follows the same principles used in any peptide reconstitution protocol. This guide covers the supplies, concentration math for common vial sizes, step-by-step mixing instructions, storage rules, and the most common mistakes researchers make. What BPC-157 Is and Why It Comes as a Powder BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide derived from a protective protein found in human gastric juice. First characterized by Sikiric et al. at the University of Zagreb, BPC-157 has been studied in over 100 preclinical trials for its effects on tissue repair, gastrointestinal protection, and angiogenesis. The peptide is supplied as a lyophilized powder because freeze-drying preserves molecular stability during shipping and storage. In this form, BPC-157 can remain stable at room temperature for months. Once reconstituted into a liquid solution, degradation begins, and the stability window shortens significantly. A 2022 pharmacokinetics study confirmed BPC-157's elimination half-life is under 30 minutes in vivo, underscorin…
STORAGE

Storage and Handling: Protecting Your Reconstituted Peptide

You've done it. You have a vial of perfectly reconstituted BPC-157. Now you have to protect it. Its stability is now entirely dependent on how you store it. Before Reconstitution: Lyophilized BPC-157 is quite stable. It can be kept at room temperature for several weeks without significant degradation, which is why it ships so well. However, for long-term storage (months), we strongly recommend keeping it in a freezer. This preserves its integrity for a year or more. After Reconstitution: Everything changes. The peptide is now in a solution where it's far more vulnerable. It must be refrigerated immediately. A standard laboratory or kitchen refrigerator (around 2-8°C or 36-46°F) is perfect. Do not freeze your reconstituted peptide. The freeze-thaw cycle can be just as damaging as shaking it, causing the peptide structure to rupture. When stored properly in the refrigerator, your reconstituted BPC-157 will remain potent and stable for about four weeks. Its exposure to light and temperature fluctuations should be minimized. Keep it in its box or in a dark part of the fridge, and only take it out for the brief moment it takes to draw a dose.
02

Question drills

Open a question for its connected answer.

01What If I'm Concerned About Immunosuppression from Biologics?+

That concern is clinically valid. TNF inhibitors and JAK inhibitors increase infection risk, particularly reactivation of latent tuberculosis or opportunistic infections. BPC-157 studied rheumatoid arthritis through a non-immunosuppressive mechanism, which theoretically avoids that risk. However, the peptide's safety profile in immunocompromised patients or those with active infections is unknown. If infection risk is driving your search for alternatives, consider conventional DMARDs like hydroxychloroquine or sulfasalazine, which carry lower immunosuppression burden than biologics, before moving to unproven peptides.

SOURCE / realpeptides.co ↗
02What If BPC-157 Modulates Receptor Trafficking Rather Than Direct Activation?+

An alternative mechanism: BPC-157 might not activate receptors directly but instead alter how growth factor receptors (like VEGFR2 or FGFR) move to the cell surface or remain active after ligand binding. Studies show the peptide increases VEGFR2 expression and phosphorylation. But doesn't bind VEGFR2 itself. If BPC-157 stabilizes receptor-ligand complexes or prevents receptor internalization, it would amplify signaling without appearing in traditional binding assays. This trafficking modulation model fits the observed data but requires live-cell imaging and membrane dynamics studies to validate.

SOURCE / realpeptides.co ↗
03What If Different Cell Lines Show Contradictory Responses to BPC-157?+

Cell line variability is real. Primary cells from human donors respond differently than immortalized cell lines, and responses vary between species (rat vs human). When contradictions appear, researchers prioritize primary human cells over immortalized lines and look for dose-dependent patterns across multiple cell sources. If BPC-157 promotes migration in primary human fibroblasts but not in an immortalized mouse line, the human primary data carries more weight for translational potential.

SOURCE / realpeptides.co ↗
04What If My Supplier Switched from BPC-157 to Bepecin Without Notice?+

Request a certificate of analysis showing amino-acid sequence verification and molecular weight confirmation. If the sequence matches Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and molecular weight falls within 1418–1421 Da, you've received the same compound under a different brand name. Verify purity is consistent with your previous batches (98% or higher via HPLC) and that endotoxin levels remain below 1 EU/mg. No protocol adjustment is necessary—the peptide's biological activity depends on structure, not labeling.

SOURCE / realpeptides.co ↗
05What If I'm Still Taking NSAIDs Daily—Can BPC-157 Work Simultaneously?+

Yes—BPC-157 can promote healing even during continued NSAID exposure, but the rate of repair depends on NSAID dose and frequency. Studies using concurrent administration showed measurable lesion reduction within 48–72 hours despite ongoing COX inhibition. The peptide's angiogenic and collagen synthesis effects operate independently of prostaglandin pathways, so they aren't blocked by NSAIDs the way misoprostol's mechanism would be. However, reducing NSAID dose or switching to selective COX-2 inhibitors (celecoxib) when medically appropriate accelerates healing because it reduces ongoing mucosal injury rate.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

BPC-157 + LL-37 Stack Research — Chronic Infection Data

Research published in peer-reviewed antimicrobial journals has documented LL-37's direct bactericidal activity against gram-negative and gram-positive species resistant to conventional antibiotics. Minimum inhibitory concentrations ranging from 1–5 μg/mL across multiple pathogen types. BPC-157, a synthetic pentadecapeptide derived from body protection compound protein sequences, operates through a completely different mechanism: modulation of nitric oxide pathways, vascular endothelial growth factor (VEGF) upregulation, and immune cell trafficking. The combination isn't redundant. It's mechanistically complementary. Our team has reviewed published literature on both peptides across hundreds of research protocols in immunology and infectious disease contexts. The pattern that emerges isn't incremental improvement. It's a fundamentally different approach to treating chronic infections that cycle between latent and active states. When a pathogen survives standard treatment by forming biofilms or entering metabolically dormant phases, you need compounds that attack multiple survival strategies simultaneously. That's the hypothesis driving current stacking bpc-157 ll-37 chronic infection research. What does stacking BPC-157 and LL-37 mean for chronic infection research? Stacking BPC-157 and LL-37 refers to concurrent administration of both peptides to leverage dual antimicrobial mechanisms. BPC-157's immune modulation and tissue repair signalling combined with LL-37's direct membrane-disrupting antimicrobial peptide activity. Research from institutions studying persistent bacterial infections has documented synergistic effects when host defense peptides like LL-37 are paired with compounds that restore immune competence at infection sites. Published protocols typically use subcutaneous BPC-157 at 250–500 mcg daily with LL-37 at 2–5 mg daily, administered separately to avoid interaction during reconstitution. The hypothesis isn't that BPC-157 kills bacteria directly. It doesn't. What it does is restore normal immune cell function in chronically inflamed tissue where white blood cell activity becomes dysregulated. LL-37 handles the bactericidal component through pore formation in pathogen membranes. This division of labor mirrors the body's own defense architecture: immune coordination plus antimicrobial execution. Most single-agent treatments excel at one or the other. Rarely both. The combination addresses what infectious disease researchers call the 'persistence gap'. Infections that never fully resolve because the immune system can't reach the pathogen, or the pathogen evades immune surveillance through biofilm formation or intracellular hiding.

RESEARCH

Limited Research

Most of the research on BPC-157 has been conducted either in vitro or on animals. These studies are less valuable than human studies, as we cannot assume that BPC-157 will behave in humans exactly as it does in animals. Tests on humans include a pilot study, which recruited 2 participants who received BPC-157 intravenously, and a Phase I human trial, which involved 47 participants, but for which the results were not published. Ideally, we would like to see more research conducted on humans to get a clearer idea of its effects on the body.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

BPC-157 Studied Sports Injury — Comparison Across Injury Types

The comparison table below synthesises findings from published BPC-157 studied sports injury research across different tissue types, highlighting which injuries show the most cons…